These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 15150682

  • 1. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E, Chiavarina B, Caviglioli G, Lapide M, Viale M.
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [Abstract] [Full Text] [Related]

  • 2. Embryo-lethal and teratogenic effect of the new platinum compound DPR in pregnant mice.
    Ognio E, Lapide M, Ottone M, Mandys V, Peterka M, Parodi B, Viale M.
    Arch Toxicol; 2003 Oct; 77(10):584-90. PubMed ID: 14574446
    [Abstract] [Full Text] [Related]

  • 3. Embryotoxicity of cisplatin and a cisplatin-procaine complex (DPR) studied in chick embryo.
    Peterka M, Mandys V, Viale M, Cafaggi S, Peterková R, Esposito M.
    Neoplasma; 2002 Oct; 49(6):394-400. PubMed ID: 12584587
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride.
    Cafaggi S, Esposito M, Parodi B, Vannozzi MO, Viale M, Pellecchia C, Fulco RA, Merlo F, Zicca A, Cadoni A.
    Anticancer Res; 1992 Oct; 12(6B):2285-92. PubMed ID: 1295476
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
    Viale M, Cafaggi S, Parodi B, Esposito M.
    Cancer Chemother Pharmacol; 1995 Oct; 35(5):371-6. PubMed ID: 7850917
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate.
    Mariggiò MA, Cafaggi S, Ottone M, Parodi B, Vannozzi MO, Mandys V, Viale M.
    Invest New Drugs; 2004 Jan; 22(1):3-16. PubMed ID: 14707490
    [Abstract] [Full Text] [Related]

  • 7. Comparative nephrotoxicity of cisplatin and new octahedral Pt(IV) complexes.
    Kim WK, Kwon YE.
    Cancer Chemother Pharmacol; 2007 Jul; 60(2):237-43. PubMed ID: 17089165
    [Abstract] [Full Text] [Related]

  • 8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.
    Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355
    [Abstract] [Full Text] [Related]

  • 10. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
    Dominguez MF, Macias RI, Izco-Basurko I, de La Fuente A, Pascual MJ, Criado JM, Monte MJ, Yajeya J, Marin JJ.
    J Pharmacol Exp Ther; 2001 Jun 30; 297(3):1106-12. PubMed ID: 11356935
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the toxicities of cisplatin and a new cisplatin-procaine complex to rat renal cortical slices.
    Zhang JG, Esposito M, Cafaggi S, Lindup WE.
    Hum Exp Toxicol; 1996 Jan 30; 15(1):59-63. PubMed ID: 8845212
    [Abstract] [Full Text] [Related]

  • 12. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
    Viale M, Pastrone I, Pellecchia C, Vannozzi MO, Cafaggi S, Esposito M.
    Anticancer Drugs; 1998 Jun 30; 9(5):457-63. PubMed ID: 9660544
    [Abstract] [Full Text] [Related]

  • 13. Neurotoxic effect of cisplatin and the cisplatin-procaine complex DPR studied in organotypic cultures of chick embryonic dorsal root ganglia.
    Mandys V, Viale M, Vrana J, Cafaggi S, Esposito M.
    Anticancer Drugs; 1998 Aug 30; 9(7):659-63. PubMed ID: 9773811
    [Abstract] [Full Text] [Related]

  • 14. The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt(II) complex on rat cerebellum.
    Cerri S, Piccolini VM, Santin G, Bottone MG, De Pascali SA, Migoni D, Iadarola P, Fanizzi FP, Bernocchi G.
    Neurotoxicol Teratol; 2011 Aug 30; 33(2):273-81. PubMed ID: 20883777
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of tetraplatin administered intraperitoneally with reduced glutathione in mice.
    Kido Y, Khokhar AR, Yoshida M, Thai GW, Siddik ZH.
    Drug Metab Dispos; 1994 Aug 30; 22(2):312-7. PubMed ID: 8013287
    [Abstract] [Full Text] [Related]

  • 16. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Zamboni WC, Gervais AC, Egorin MJ, Schellens JH, Hamburger DR, Delauter BJ, Grim A, Zuhowski EG, Joseph E, Pluim D, Potter DM, Eiseman JL.
    Clin Cancer Res; 2002 Sep 30; 8(9):2992-9. PubMed ID: 12231546
    [Abstract] [Full Text] [Related]

  • 17. Improved pharmacological profile of the lipophilic antitumor dichloro-(N-dodecyl)-propanediamine-platinum(II) complex after incorporation into pegylated liposomes.
    Silva H, Silva AC, Lemos FO, Monte-Neto RL, Fontes AP, Lopes MT, Frézard F.
    Anticancer Drugs; 2013 Feb 30; 24(2):131-9. PubMed ID: 23011234
    [Abstract] [Full Text] [Related]

  • 18. Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?
    Viale M, Vannozzi MO, Pastrone I, Mariggiò MA, Zicca A, Cadoni A, Cafaggi S, Tolino G, Lunardi G, Civalleri D, Lindup WE, Esposito M.
    J Pharmacol Exp Ther; 2000 Jun 30; 293(3):829-36. PubMed ID: 10869382
    [Abstract] [Full Text] [Related]

  • 19. Platinum levels in murine tumor following intraperitoneal administration of cisplatin or paraplatin.
    Douple EB, Totten MD, Spencer F.
    NCI Monogr; 1988 Jun 30; (6):129-32. PubMed ID: 3281028
    [Abstract] [Full Text] [Related]

  • 20. A Phase I and pharmacological study of the platinum polymer AP5280 given as an intravenous infusion once every 3 weeks in patients with solid tumors.
    Rademaker-Lakhai JM, Terret C, Howell SB, Baud CM, De Boer RF, Pluim D, Beijnen JH, Schellens JH, Droz JP.
    Clin Cancer Res; 2004 May 15; 10(10):3386-95. PubMed ID: 15161693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.